World Health Organization. Child mortality and causes of death. WHO, https://www.who.int/gho/child_health/mortality/mortality_under_five_text/en/ (2020).
Pollard, A. J. & Bijker, E. M. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol. 21, 83–100 (2021).
Article CAS PubMed Google Scholar
Cao-Lormeau, V. M. et al. Guillain–Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case–control study. Lancet 387, 1531–1539 (2016).
Article PubMed PubMed Central Google Scholar
Patone, M. et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 27, 2144–2153 (2021).
Article CAS PubMed PubMed Central Google Scholar
& Barwick Eidex, R. Yellow Fever Vaccine Safety Working Group. History of thymoma and yellow fever vaccination.Lancet 364, 936 (2004).
Nath, A. Neurologic complications with vaccines: what we know, what we don’t, and what we should do. Neurology 101, 621–626 (2023).
Article PubMed PubMed Central Google Scholar
Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).
Article CAS PubMed Google Scholar
Perry, R. J. et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet 398, 1147–1156 (2021).
Article CAS PubMed PubMed Central Google Scholar
Godlee, F., Smith, J. & Marcovitch, H. Wakefield’s article linking MMR vaccine and autism was fraudulent. BMJ 342, c7452 (2011).
Waugh, C. J., Willocks, L. J., Templeton, K. & Stevenson, J. Recurrent outbreaks of mumps in Lothian and the impact of waning immunity. Epidemiol. Infect. 148, e131 (2020).
Article CAS PubMed PubMed Central Google Scholar
Baker, J. P. The pertussis vaccine controversy in Great Britain, 1974–1986. Vaccine 21, 4003–4010 (2003).
Larson, H. J., Gakidou, E. & Murray, C. J. L. The vaccine-hesitant moment. N. Engl. J. Med. 387, 58–65 (2022).
Article CAS PubMed Google Scholar
Knipe, D. M., Levy, O., Fitzgerald, K. A. & Muhlberger, E. Ensuring vaccine safety. Science 370, 1274–1275 (2020).
Article CAS PubMed Google Scholar
Folegatti, P. M. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 396, 467–478 (2020).
Article CAS PubMed PubMed Central Google Scholar
Ramasamy, M. N. et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 396, 1979–1993 (2021).
Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2 — preliminary report. N. Engl. J. Med. 383, 1920–1931 (2020).
Article CAS PubMed Google Scholar
Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99–111 (2021).
Article CAS PubMed PubMed Central Google Scholar
Scully, M. et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med. 384, 2202–2211 (2021).
Article CAS PubMed Google Scholar
Candore, G. et al. Comparison of statistical signal detection methods within and across spontaneous reporting databases. Drug. Saf. 38, 577–587 (2015).
Article CAS PubMed Google Scholar
Lazarus, R. et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet 398, 2277–2287 (2021).
Article CAS PubMed PubMed Central Google Scholar
Verani, J. R. et al. Case–control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls. Vaccine 35, 3295–3302 (2017).
Article PubMed PubMed Central Google Scholar
Farrington, P. The self-controlled case series method and covid-19. BMJ 377, o625 (2022).
Minor, P. D. Live attenuated vaccines: historical successes and current challenges. Virology 479–480, 379–392 (2015).
Norrby, E. Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine. J. Exp. Med. 204, 2779–2784 (2007).
Article CAS PubMed PubMed Central Google Scholar
Baicus, A. History of polio vaccination. World J. Virol. 1, 108–114 (2012).
Article PubMed PubMed Central Google Scholar
Mangtani, P. et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin. Infect. Dis. 58, 470–480 (2014).
Poyhonen, L., Bustamante, J., Casanova, J. L., Jouanguy, E. & Zhang, Q. Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity. J. Clin. Immunol. 39, 376–390 (2019).
Article PubMed PubMed Central Google Scholar
Reno, E. et al. Prevention of yellow fever in travellers: an update. Lancet Infect. Dis. 20, e129–e137 (2020).
Article CAS PubMed Google Scholar
Garske, T. et al. Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med. 11, e1001638 (2014).
Article PubMed PubMed Central Google Scholar
Gianchecchi, E., Cianchi, V., Torelli, A. & Montomoli, E. Yellow fever: origin, epidemiology, preventive strategies and future prospects. Vaccines 10, 372 (2022).
Article PubMed PubMed Central Google Scholar
Staples, J. E., Gershman, M., Fischer, M. & Centers for Disease Control and Prevention. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 59, 1–27 (2010).
de Abreu, A. J. L., Cavalcante, J. R., de Araujo Lagos, L. W., Caetano, R. & Braga, J. U. A systematic review and a meta-analysis of the yellow fever vaccine in the elderly population. Vaccines 10, 711 (2022).
Article PubMed PubMed Central Google Scholar
Kitchener, S. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®. Vaccine 22, 2103–2105 (2004).
留言 (0)